Robot-assisted closed reduction and fixation for distal femur fractures
Official title: Key Technology Research and Development for Intelligent Minimally Invasive Precision Treatment of Fractures (Sub-project 3: A Randomized Controlled Trial of Robot-Assisted Closed Reduction and Internal Fixation for Supracondylar Femoral Fractures)
Run by Beijing Jishuitan Hospital · NCT07738406 · Data updated 2026-11-12
This study tests whether a smart robotic system can help doctors realign extra-articular supracondylar femur fractures more precisely and with less radiation than conventional methods in adults aged 18–80.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Beijing Jishuitan Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Beijing, Beijing Municipality and 1 other locations) |
| Status | Recruiting |
| Started | July 1, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT07738406 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 with unilateral acute closed extra-articular supracondylar femoral fractures (AO/OTA 33-A) eligible for surgical reduction.
✕Probably not a fit
Patients with open fractures, multiple traumas, prior femur deformities, or other conditions that preclude standard evaluation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares robot-assisted closed reduction with traditional surgeon-led reduction for supracondylar femoral fractures (AO/OTA 33-A). The study aims to determine if the robotic system improves anatomical alignment and functional recovery while reducing radiation exposure from fluoroscopy. Participants are adults with acute unilateral closed fractures, eligible if surgery can occur within 21 days and they can walk independently before injury. The trial will assess safety and efficacy of the robotic approach versus conventional fixation. No phase designation is reported.
Why it matters
Potential benefit: If successful, patients may experience more accurate bone alignment, better functional outcomes, and less radiation exposure during surgery.
How similar studies have gone: Prior studies in robotic fracture reduction have shown promise in improving alignment, but evidence remains variable and this trial adds contemporary, automated guidance.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 80 years old * Unilateral, acute, closed extra-articular supracondylar femoral fracture (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association AO/OTA 33-A) * Time from injury to surgery ≤21 days * Able to walk independently before injury (assistive devices allowed) Exclusion Criteria: * Open fractures or multiple severe traumas requiring priority treatment * Asymmetrical lower extremities, or prior malunion of the ipsilateral femur, or pre-existing deformities significantly affecting rotation/length evaluation * Unilateral fractures combined with other sites * Pathological fractures (tumor or metabolic) * Prior complex implants in place or previous surgeries significantly affecting evaluation * Active infection or severe systemic medical contraindications (unable to tolerate anesthesia/surgery) * Cognitive impairment, poor compliance, pregnancy, or lactation * Deemed unsuitable by the investigator (e.g., unable to follow up, or extreme obesity severely limiting the surgical or robotic workspace) * Refused randomization or enrollment
Where it's running
-
Aerospace Center Hospital
Beijing, Beijing Municipality, China Recruiting -
Beijing Jishuitan Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Chunpeng Zhao, MD / Chief Physician
- Email: zcpllza2008@163.com
- Phone: +86 18610012704
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preoperative Oral Nutrition for Frail Elderly Hip Fracture Patients
This observational study tests whether giving preoperative oral nutrition helps frail elderly patients with femur fractures fare better around surgery.
-
CoCrMo LOCK bipolar hip head safety and performance after hemiarthroplasty
This study tests whether CoCrMo LOCK bipolar femoral heads perform safely and reliably after hip hemiarthroplasty in adults with displaced intracapsular hip fractures.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
-
Bone marrow injection at the femoral neck fracture site in young adults with intracapsular hip fractures
This study tests whether injecting the patient’s own bone marrow into a femoral neck fracture helps it heal faster and reduces avascular necrosis in adults aged 18–55 with certain fracture types.
-
Tipmed™ Primary Hip Prosthesis: 24-Month Post-Market Follow-Up in Adults
This PMCF study tests the safety and 24‑month performance of the Tipmed hip prosthesis in adults undergoing primary hip replacement.
-
Sacral ESPB versus PENG nerve block for pain after hip hemiarthroplasty
We will see if a sacral erector spinae plane (S-ESPB) block or a pericapsular nerve group (PENG) block gives better pain relief for adults 50–90 having hip hemiarthroplasty for a femoral neck fracture.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.